Early Access — free while we kick the tires
EdgarHawk

Adam R Kalbermatten

President-Chief Commercial Off

Officer

Latest: President-Chief Commercial Off buying · June 2026

1 filing analyzed · 1 company · Latest 2026-06-15

Never miss a filing from Adam R Kalbermatten

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
KORU Medical Systems, Inc. KRMD 1 0 Net buying

Activity

June 2026
medium
Buy
12,500 shares
$49,275
Significance 6/10

President-Chief Commercial Officer Adam Kalbermatten purchases 12,500 shares for $49,275.00 at KRMD; holdings rise to 312,500 shares.

Adam Kalbermatten executed 2 purchases totaling 12,500 shares for $49,275.00, bringing his post-transaction holdings to 312,500 shares (+4.2% vs pre-transaction holdings of 300,000 shares). The blended average purchase price of $3.94 trades above the current price of $3.87, while the stock remains -41.4% from its 52-week high of $6.61. KRMD is unprofitable on a full-year basis with net income of $-807,078.00 in the latest quarter, though the company posted annual revenue growth of +22.2% and a market cap of $177,760,710.00. The transaction occurred as the stock has declined 9.4% over the past 90 days, presenting context for an officer-level accumulation by a senior commercial executive.

Related insiders